Adaxion Therapeutics is a startup based in the United States.
Adaxion Therapeutics is a company headquartered in the United States.
Adaxion Therapeutics develops biologic therapies for immune-mediated and inflammatory diseases by using a proprietary ADAx platform that reduces immunogenicity through targeted elimination of therapeutic-specific B cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.